TD Asset Management Inc Has $86.10 Million Stock Position in Encompass Health Corporation $EHC

Posted by Brian Himes on Jun 5th, 2026

TD Asset Management Inc reduced its position in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 12.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 811,173 shares of the company’s stock after selling 112,010 shares during the quarter. TD Asset Management Inc’s holdings in Encompass Health were worth $86,098,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in EHC. Northwestern Mutual Wealth Management Co. raised its stake in Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after buying an additional 3,793,358 shares during the period. Norges Bank acquired a new position in Encompass Health during the 4th quarter worth approximately $133,221,000. Millennium Management LLC raised its stake in Encompass Health by 140.0% during the 3rd quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock worth $155,430,000 after buying an additional 713,738 shares during the period. 8 Knots Management LLC acquired a new position in Encompass Health during the 2nd quarter worth approximately $78,644,000. Finally, Alliancebernstein L.P. raised its stake in shares of Encompass Health by 23.4% in the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after purchasing an additional 476,564 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

EHC has been the subject of several analyst reports. Barclays lowered their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Leerink Partners set a $152.00 price objective on Encompass Health in a research note on Friday, May 22nd. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, TD Cowen initiated coverage on Encompass Health in a research note on Thursday, May 28th. They issued a “buy” rating and a $125.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $143.86.

Read Our Latest Report on EHC

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $100.02 on Friday. The company has a market cap of $9.92 billion, a PE ratio of 16.70, a price-to-earnings-growth ratio of 2.25 and a beta of 0.72. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99. The business has a 50 day moving average price of $103.68 and a 200-day moving average price of $105.01. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.09. The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.Encompass Health’s quarterly revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities analysts anticipate that Encompass Health Corporation will post 5.97 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.8%. Encompass Health’s dividend payout ratio is currently 12.69%.

Insider Activity at Encompass Health

In other news, Treasurer Edmund Fay sold 11,937 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares of the company’s stock, valued at $9,557,775. This represents a 11.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Patrick William Tuer sold 682 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.